VVOS today
$0.09-$0.00 (-2.32%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minStrong Bullish
Daily trend turns up above $0.14
Key levels
Resistance$0.13
Resistance$0.12
Latest news & SEC filings
SEC FilingVivos Therapeutics, Inc. filed an insider trading report (Form 4)
LegalNasdaq listing rule satisfied again by Vivos Therapeutics
All VVOS news →About Vivos Therapeutics
Vivos Therapeutics develops oral devices and related treatment programs for sleep and breathing conditions, including obstructive sleep apnea and snoring. Its main offerings are its patented oral appliances, such as the DNA, mRNA, and mmRNA devices, which have FDA clearance for mild to severe OSA in adults and certain children. The company also provides diagnostic tools, myofunctional therapy, and other supportive services. It serves dentists, medical providers, and sleep centers, and operates in the United States through trained providers and acquired sleep practices.
Based on the company's 10-K filed Apr 15, 2026.
Nasdaq · Healthcare
Vivos Therapeutics, Inc. (VVOS)
What Is the Price Target for VVOS?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is VVOS a Buy or Sell Right Now?
Thesis
- •Revenue growing 16.1% YoY with ACCELERATING trend — accelerating momentum.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment stable.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for VVOS.
Start Free Trial →Is VVOS Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
PEG
Fair Value
$0.15
52
Moat Score
NARROW
2/9
Piotroski Score
-9.5
Altman Z-Score
What Is Smart Money Doing with VVOS?
Insider Signal
NEUTRAL
2 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Huntsman Ronald Kirk | director officer | Buy | 85,910 | $50K | Jun 30, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →VVOS Growth Story
Revenue YoY
16.1%
3yr Revenue CAGR
N/A%
EPS Growth YoY
6.76%
FCF Growth YoY
-32.8%
Revenue Trend
ACCELERATING
Dark Pool Trades for VVOS
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for VVOS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 18:10:57 | $0.09 | 2,700 | $$238 | SELL |
| 18:10:57 | $0.09 | 2,929 | $$258 | SELL |
| 18:10:57 | $0.09 | 1,354 | $$119 | SELL |
| 17:49:09 | $0.09 | 10,000 | $$880 | SELL |
| 17:15:05 | $0.09 | 1,825 | $$160 | SELL |
5 dark pool trades shown · $$2K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Vivos Therapeutics, Inc. (VVOS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →VVOS — frequently asked questions
What is VVOS stock price today?
Vivos Therapeutics, Inc. (VVOS) is at $0.09, down 2.32% (-$0.00) at the Nov 12, 2026 close.
Why is VVOS stock moving today?
Latest VVOS news — Oct 26, 2026: Vivos Therapeutics, Inc. filed an insider trading report (Form 4) · Oct 21, 2026: Nasdaq listing rule satisfied again by Vivos Therapeutics
What do analysts rate VVOS?
Analyst ratings for VVOS: 0 Buy, 3 Hold, 0 Sell — consensus Hold.
Did VVOS beat earnings?
VVOS last reported on Aug 14, 2026: EPS -$0.31 vs -$0.41 expected — a beat of 24.4%.
Does VVOS pay a dividend?
VVOS does not currently pay a dividend.
How much debt does VVOS have?
Vivos Therapeutics, Inc. reported $1M of debt and $2M of cash (Jun 30, 2026).
What are VVOS support and resistance levels?
Resistance: $0.12, $0.13, $0.14.
What are insiders doing with VVOS?
Insider activity: NEUTRAL, 2 buys and 0 sells in the last 90 days.
What is the latest news on VVOS?
Oct 26, 2026: Vivos Therapeutics, Inc. filed an insider trading report (Form 4) · Oct 21, 2026: Nasdaq listing rule satisfied again by Vivos Therapeutics